Menin affects histone H3 methylation status and recruits the nuclear complex mixed-lineage leukemia 1 and 2 (MLL1 and MLL2), which binds to promoter regions of CDK inhibitors (CDKN2C and CDKN1B) to inhibit tumor formation [144,145]. Here, KMT2A is linked to neoplasm.